Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 1009-1015

  Parmar, Kalindi ^a   Rosenberg, Naomi ^a,b  

^a Department of Pathology ^*  (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; ONCOPROTEIN; PHOSPHOTYROSINE; RAS PROTEIN;

ABELSON MURINE LEUKEMIA ONCOVIRUS; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN 3T3; CONTROLLED STUDY; LYMPHOCYTE TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE H RAS; ONCOGENE RAS; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS MUTANT;

EID: 0030032293     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.1009-1015.1996     Document Type: Article

References (56)

1. Alexander, W. S., J. M. Adams, and S. Cory. 1989 Oncogenic cooperation in lymphocyte transformation: malignant conversion of Eμ-myc transgenic pre-B cell in vitro is enhanced by v-Ha-ras or v-raf but not v-abl. Mol Cell Biol. 9:67-73
2. Boguski, M. S., and F. McCormick. 1993. Proteins regulating Ras and its relatives Nature (London) 366:643-654.
3. Chang, E. H., J. M. Maryak, C. M. Wei, T. Y. Shih, R. Shober, H. L. Chueng, R. W. Ellis, G. L. Hager, E. M. Scolnick, and D. R. Lowy. 1980 Functional organization of the Harvey murine sarcoma virus genome. J. Virol 35:76-92.
4. Chen, Y. Y., L. C. Wang, M. S. Huang, and N. Rosenberg. 1994. An active v-Abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes Dev. 8:688-697.
5. Chesbro, B., K. Wehrly, M. Cloyd, W. Britt, J. Portis, J. Collins, and J. Nishio. 1981. Characterization of mouse mono-clonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens Virology 112:131-144.
6. Druker, B., K. Okuda, U. Matulonis, R. Salgia, T. Roberts, and J. D. Griffin. 1992. Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines Blood 79:2215-2220.
7. Ellis, C., M. Moran, F. McCormick, and T. Pawson. 1990. Phobphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature (London) 343:377-381.
8. Engelman, A., and N. Rosenberg. 1987. Isolation of temperature sensitive Abelson virus mutants by site-directed mutagenesis. Proc. Natl. Acad. Sci. USA 84:8021-8025.
9. Engelman, A., and N. Rosenberg. 1990 Temperature-sensitive mutant of Abelson murine leukemia virus deficient in protein tyrosine kinase activity J. Virol. 64:4242-4251.
10. Engelman, A., and N. Rosenberg. 1990. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation. Mol Cell. Biol 10:4365-4369
11. Feller, S. M., B. Knudsen. and H. Hanafusa. 1994. c-Abl kinase regulates the protein binding activity of c-Crk EMBO J. 13:2341-2351.
12. Goga, A., J. McLaughlin, A. M. Pendergast, K. Parmar, A. Muller, N. Rosenberg, and O. N. Witte, 1993. Oncogenic activation of c-ABL by mutation within its last exon. Mol. Cell. Biol. 13:4967-4975.
13. Hall, A. 1990. ras and GAP-who's controlling whom? Cell 61:921-923
14. Hanks, S. K., A. M. Quinn, and T. Hunter. 1988 The protein kinase family: conserved features and deduced phytogeny of the catalytic domains. Science 241:42-52.
15. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hajakawa. 1991 Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow J. Exp Med 173:1213-1225.
16. Henkenmeyer, M., S. R. West, F. B. Gertler, and F. M. Hoffman. 1990 A novel tyrosine kinase-independent function of drosophila abl correlates with proper subcellular localization. Cell 63:949-960.
17. Henkenmeyer, M. J., R. L. Bennet, F. B. Gertler, and F. M. Hoffman. 1988. DNA sequence, structure, and tyrosine kinase activity of Drosophila mela-nogaster Abelson proto-oncogene homology. Mol. Cell. Biol. 8:843-853
18. Hevezi, P., K. Alin, R. Rees-Jones, and S. Goff. 1992. Bone marrow-trans-forming activity of linker insertion mutants of Abelson murine leukemia virus. Oncogene 7:2323-2328.
19. Holmes, K. L., J. H. Pierce, W. F. Davidson, and H. C. Morse III. 1986. Murine hematopoietic cells with pre-B or pre-B'myeloid characteristic are generated by in vitro transformation with retroviruses containing fes. ras. abl. and src. oncogenes. J. Exp Med 164:443-457.
20. Kipreos, E. T., and J. Y. J. Wang. 1990. Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity. Science 248:217-220.
21. Kipreos, E. T., and J. Y. J. Wang. 1992. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256:382-385.
22. Knudsen, B. S., S. M. Feller, and H. Hanafusa. 1994. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk. J Biol Chem. 269: 32781-32787.
23. Koch, C. A., D. Anderson, M. F. Moran, C. Ellis, and T. Pawson. 1991 SH2 and SH3 domains: elements that control interactions of cytoplasmic sigraling molecules. Science 252:668-674.
24. Konopka. J. B., and O. N. Witte. 1985. Detection of c-Abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol. Cell Biol. 5:3116-3123.
25. Kruh, G. D., R. Perego, T. Miki, and S. A. Aaronson. 1990. The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc. Natl. Acad Sci. USA 87:5802-5806.
26. Lee, R., M. Paskind, J. Y. J. Wang, and D. Baltimore. 1985. Abelson (P160) murine leukemia virus (Ab-MuLV) abl gene, p 861-868 in R Weiss N Teich, H. Varmus, and J. Coffin (ed.). RNA tumor viruses-1985. Cold Spring Harbor Laboratory. Cold Spring Harbor. N.Y.
27. Lugo, T. G., A. M. Pendergast, A. J. Muller, and O. N. Witte. 1990. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products Science 247:1079-1082.
28. Matsuda, M., Y. Hashimoto, K. Muroya, H. Hasegawa, T. Kurata, S. Tanaka, S. Nakamura, and S. Hattori. 1994 CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol. Cell Biol. 14:5495-5500
29. McWhirter, J. R., and J. Y. J. Wang. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J 12:1533-1546.
30. Melton, D. A. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035-7056
31. Molloy, C. J., D. P. Bottaro, T. P. Fleming, M. S. Marshall, J. B. Gibbs, and S. A. Aaronson. 1989 PDGF induction of tyrosine phosphorylation of GT-Pase activating protein. Nature (London) 342:711-714.
32. ras GTPase-activating protein. Mol. Cell. Biol. 11:1804-1812.
33. Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell Biol. 11:1785-1792.
34. Murtagh, K., G. Skladany, J. Hoag, and N. Rosenberg. 1986. Abelson murine leukemia virus variants with increased oncogenic potential. J. Virol. 60:599-606.
35. Owen-Lynch, P. J., A. K. Y. Wong, and A. D. Whetton. 1995. v-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation. J. Biol. Chem. 270: 5956-5962
36. Parmar, K., R. C. Huebner, and N. Rosenberg. 1991. Carboxyl-terminal determinants of Abelson protein important for lymphoma induction. J. Virol. 65:6478-6485.
37. Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai. N. Li. A, Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, and M. L. Gishizky. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175-185
38. Pendergast, A. M., J. A. Traugh, and O. N. Witte. 1987. Normal cellular and transformation-associated abl proteins share common sites for protein kinase C phosphorylation. Mol. Cell. Biol. 7:4280-4289.
39. Prywes, R., J. G. Foulkes, N. Rosenberg, and D. Baltimore. 1983 Sequence of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell 34:569-579.
40. Reddy, E. P., M. J. Smith, and A. Srinivasan. 1983. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other one gene products with tyrosine-specific kinase activity Proc Natl Acad. Sci. USA 80:3623-3627.
41. Ren, R., Z. Ye, and D. Baltimore. 1994 Abl protein-tyrosine kinase selects the Crk adaptor as a substrate using SH3-bindina sites. Genes Dev 8:783-795.
42. Roseaberg, N., and D. Baltimore. 1976. A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J. Exp. Med. 145:1126-1141.
43. Rosenberg, N., D. R. Clark, and O. N. Witte. 1980. Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid transformation. J. Virol. 36:765-774
44. Rosenberg, N., and O. N. Witte. 1988. The viral and cellular forms of the Abelson (abl) oncogene, p. 39-81. In A. Shatkin (ed.). Advances in virus research. Academic Press, New York.
45. ras-GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc. Natl. Acad. Sci. USA 87:7926-7929.
46. Sawyers, C. L., J. McLaughlin, and O. N. Witte. 1995 Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J Exp. Med. 181:307-313.
47. Scher, C. D., and R. Siegler. 1975. Direct transformation of 3T3 cells by Abelson murine leukemia virus. Nature (London) 253:729-731.
48. Schiff-Maker, L., M. C. Burns, J. B. Konopka, S. Clark, O. N. Witte, and N. Rosenberg. 1986. Monoclonal antibodies specific for v-abl. and c-abl-en-coded molecules. J Virol. 57:1182-1186
49. ml mutation show poor viability and depletion of selected B and T cell populations. Cell 65:1165-1175.
50. Sefton, B. M., T. Hunter, and W. C. Raschke. 1981. Evidence that the Abelson virus protein functions in vivo as a protein tyrosine kinase that phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA 78:1552-1556.
51. Shtivelman, E., B. Lifshitz, R. P. Gale, B. A. Roe, and E. Canaani. 1986. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47:277-284.
52. Smith, M. R., S. J. DeGudicibus, and D. W. Stacey. 1986. Requirement for c-ras proteins during viral oncogene transformation. Nature (London) 320: 540-543.
53. Van Etten, R. A., P. Jackson, and D. Baltimore. 1989. The mouse type-IV c-abl product is a nuclear protein and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669-678.
54. Van Etten, R. A., P. K. Jackson, D. Baltimore, M. C. Sanders, P. T. Matsudaria. and P. A. Janmey. 1994 The COOH terminus of the c-Abl tyrosine kinase contains distinct F and G-actin binding domains with bundling activity J Cell Biol. 124:325-340.
55. Wang, L. C., Y. Y. Chen, and N. Rosenberg. 1994. Prc-B cells transformed by ts Abelson virus rearrange κ and λ genes in early G1. Curr. Top Microbiol. Immunol 194:355-361
56. Watanabe, S. M., and O. N. Witte. 1983. Site-directed deletions of Abelson murine leukemia virus define 3 sequences essential for transformation and lethality J. Virol. 45:1028-1036.